News List

Print
Press Enter to show all options, press Tab go to next option

Sara A. Hurvitz, MD, on HR+, HER2- Breast Cancer

Results of the neoMONARCH Trial

Post Date:12/15/2016 10:11 AM

Sara A. Hurvitz, MD, of the UCLA Jonsson Comprehensive Cancer Center, discussed findings on the biological effects of abemaciclib in a neoadjuvant study for postmenopausal patients at #SABCS16 (Abstract S4-06).

http://www.ascopost.com/videos/2016-san-antonio-breast-cancer-symposium/sara-a-hurvitz-md-on-hrplus-her2-breast-cancer-results-of-the-neomonarch-trial/

Return to full list >>